CBD Oil Depot https://cbdoildepo.com Fri, 20 Sep 2019 08:49:45 +0000 en-US hourly 1 https://wordpress.org/?v=5.2.3 Top 5 Treatments for Anxiety Disorders https://cbdoildepo.com/top-5-treatments-for-anxiety-disorders/ https://cbdoildepo.com/top-5-treatments-for-anxiety-disorders/#respond Fri, 20 Sep 2019 08:49:45 +0000 https://cbdoildepo.com/top-5-treatments-for-anxiety-disorders/ Feel Anxious? Talk to Someone Now These are my Top 5 Treatments for Anxiety because they work for me! There are millions of things you can do to treat your anxiety that can range from a new diet, exercises and sleeping habits. The way we treat anxiety is different for everyone who experiences these nasty…

The post Top 5 Treatments for Anxiety Disorders appeared first on CBD Oil Depot.

]]>

Feel Anxious? Talk to Someone Now

These are my Top 5 Treatments for Anxiety because they work for me! There are millions of things you can do to treat your anxiety that can range from a new diet, exercises and sleeping habits. The way we treat anxiety is different for everyone who experiences these nasty symptoms. What’s important is that we realize how many options are out there and how accessible they are!

Don’t forget to keep the promise you made at the beginning of the video. You have to try each of these things and not give up if they do not work. It goes without saying that if you are not going to ever take medication, don’t do it just for the heck of it because you made a promise to Scott. What I mean is that for the meditation and things you can basically do for free, stick with them for the long haul. Everything is difficult before it is easy but this should not discourage you from creating new rituals.

Anxiety will continue to be a pain in the ass for you if you’re not willing to try new things and get out of your comfort zone. Practicing yoga may mean you get up earlier during the week. Seeing a psychologist may mean that you experience way more anxiety than normal during your first session. Sometimes there is a cost to mental health but let’s not quit before we even start.
You got this!

Scott’s Mental Health Picks

Professional Online Therapy:
Official Merch:
My CBD Pen 15% off with code ‘depressiontoexpression’:
My CBD Vape Oil 20% off with code ‘DTE20’:
My Native American Flute – Key of A:
My Meditation Bowl 13% off with code ‘SILENTVM’:
My Weighted Blanket 10% off:

Want a bunch of awesome perks? Join our private community on Patreon and you get (just to name a few):
My E-Book – Beat Depression and Anxiety Through Expression
Vote for Video Topics (Music, Games, Mental Health)
Exclusive Videos
Skype with Me!
Monthly Private Patreon Q+A
Sign Up Here:

Listen to the Depression to Expression Podcast:
iTunes:
Spotify:
Google Music:

Social Links

SUBSCRIBE:
INSTAGRAM:
FACEBOOK:
TWITTER:
WEBSITE:
QUESTIONS? scott@depressiontoexpression.com

My YouTube Studio Set-Up

Canon M50:
Rode Videomic Pro:
20mm EFM Canon Lens:
Screen Recording (OBS Software):
USB Yeti Microphone (Podcast and Gaming):

Speak to a professional counselor or therapist online today:

If you are in crisis, people are waiting to hear from you:

Our Mission: Create an honest dialogue about mental health by educating and inspiring people to express themselves freely with confidence

#mentalhealth #depressiontoexpression
Depression to Expression stands for Fearless Expression. Comment and share your thoughts and insights with the world. We all have a voice and our truth should be expressed in a respectable, dignified manner. This community is full of awesome people and I’m so happy to welcome you!

The post Top 5 Treatments for Anxiety Disorders appeared first on CBD Oil Depot.

]]>
https://cbdoildepo.com/top-5-treatments-for-anxiety-disorders/feed/ 0
What Studies Say About Cannabis’ Effect on Various Health Conditions – tntribune.com https://cbdoildepo.com/what-studies-say-about-cannabis-effect-on-various-health-conditions-tntribune-com/ Fri, 20 Sep 2019 07:39:20 +0000 http://CBMidGh0dHBzOi8vdG50cmlidW5lLmNvbS9saWZlc3R5bGUvaGVhbHRoLXdlbGxuZXNzL3doYXQtc3R1ZGllcy1zYXktYWJvdXQtY2FubmFiaXMtZWZmZWN0LW9uLXZhcmlvdXMtaGVhbHRoLWNvbmRpdGlvbnMv0gEA April 16, 2019 – Casselberry, Florida, United States – Patients place orders for medical marijuana at a new Knox medical marijuana dispensary on April 16, 2019 in Casselberry, Florida. Florida lawmakers are proposing a 10 percent cap in THC levels for whole flower medical marijuana products for smoking. By Sari […]

The post What Studies Say About Cannabis’ Effect on Various Health Conditions – tntribune.com appeared first on CBD Oil Depot.

]]>
April 16, 2019 – Casselberry, Florida, United States – Patients place orders for medical marijuana at a new Knox medical marijuana dispensary on April 16, 2019 in Casselberry, Florida. Florida lawmakers are proposing a 10 percent cap in THC levels for whole flower medical marijuana products for smoking.

By Sari Harrar, AARP

Evaluating medical marijuana research disease by disease is not easy, hampered as it is by the federal government’s ban on government-supported data collection. Observational studies — in which users simply report their experiences — may look rosy. Animal and test-tube studies also can sound promising. But plenty of stuff that helps mice or a clump of cells in a petri dish may not help us humans. Despite these obstacles, there are some conditions and diseases for which cannabis is clearly a useful treatment. Others, not so much.

Chronic pain. More than 600,000 Americans turn to cannabis for relief from chronic pain — and the scientific evidence for its effectiveness is substantial. In gold-standard randomized clinical trials of people who had agonizing health concerns — peripheral neuropathy (nerve pain from diabetes), spinal cord injury, HIV or complex regional pain syndrome, cancer, chemotherapy, muscle and joint problems, rheumatoid arthritis and multiple sclerosis — cannabis reduced pain by 40 percent, according to the 2017 NASEM report.

In a recent Canadian study, cannabis even soothed arthritic lab rats. Surprisingly, there’s little evidence (yet) from human studies for the most common form of arthritis, osteoarthritis — the wear-and-tear joint disease affecting 50 percent of adults age 65-plus. Clinical trials are underway. But who’s waiting? Arthritis was the top reason older adults used cannabis in a 2019 Colorado survey, followed by back pain. Overall, 79 percent said it helped. 

Insomnia. The National Academies rate scientific proof for better sleep on cannabis as only “moderate” in people with health conditions that interfere with slumber. But that’s not slowing down older users. More than 1 in 3 people in a Colorado survey tried it for sleep; 86 percent said it helped. By plugging into cannabinoid receptors on brain cells, THC and CBD could possibly team up for better sleep, at least in the short term, in people with insomnia due to pain, obstructive sleep apnea, fibromyalgia, multiple sclerosis and anxiety.

But beware: Choosing cannabis for sleep can be tricky. A little THC helps, but too much could keep you awake. Too little CBD could interfere with good sleep, while a bigger dose may help you snooze longer with fewer overnight wake-ups, a recent Palo Alto University review says.

Depression, anxiety and PTSD. Lifting low moods and calming chronic tension brought 1 in 5 older adults in a recent survey to medical cannabis. More than 90 percent said it helped. Meanwhile, treatment of post-traumatic stress disorder (PTSD) is emerging as another top use.

So far, data for all of these mental health issues is sparse. We’ll know more soon. At least seven studies of cannabis in anxiety and/or depression are in the works in the United States and around the world. So are at least six studies for PTSD. 

For now, small studies and surveys hint at benefits and problems — especially for depression. The good news: In a 2018 Washington State University online survey of 3,151 medical marijuana users with depression, in-the-moment symptoms improved by 50 percent after just two puffs of generally low-THC, high-CBD pot. As with any drug, dosage matters: More wasn’t better. The bad news: Over time, their ongoing depression worsened somewhat. Regular use may change cannabinoid receptors in the brain, boosting vulnerability to dark moods, the researchers note. Stopping can reverse it.

Note: Potency varies by strain and form, and it can often be tough to gauge a patient’s tolerance. So before a patient engages in a cannabis-based medical treatment, he or she should consult their doctor and approach with caution; there’s limited scientific research and, as with any medication, the effects vary by user.

The picture looks brighter for anxiety — if you choose your cannabis carefully. In a 2018 study, volunteers who used cannabis reduced their use of commonly prescribed anxiety-reducing benzodiazepines by 47 percent. Users are enthusiastic. “Anxiety can really increase as you get older,” notes Barbara Blaser, 73, a nurse navigator who helps teach older cannabis users at Magnolia Wellness dispensary in Oakland, California. “Your kids are far away, your friends are passing away, you don’t know what will happen next in your life. A small amount of cannabis can help you feel better. Right now, I’m using a gel pen that delivers a tiny dab to my skin. It sinks in and I relax.” 

Quantity matters: A little bit (7.5 milligrams of THC, less than the content of many edibles) reduced stress in a 2017 study. But 12.5 milligrams (what you’d get from a few puffs of the popular pot strain GSC (formerly Girl Scout Cookies) increased anxiety.

Cannabis has potential for people with PTSD. THC and CBD may soften “fear memories” that flood the brain in response to PTSD triggers (such as a sudden loud noise), say researchers from the National Center for PTSD in Palo Alto, California. Taking THC at night meant fewer and less intense nightmares for 47 people with PTSD in a 2009 clinical trial in Canada. 

BOTTOM LINE: Depression — mixed success; anxiety — seems to help; PTSD — seems to help

Multiple sclerosis. Nearly 1 million Americans, including many 45 and older, live with the debilitating muscle spasms and pain of multiple sclerosis. Up to 66 percent of them may be using medical marijuana, a 2017 survey found. It’s likely they’ve cut back on MS medications, too. In fact, people with MS are the second-largest group of medical marijuana users in the U.S., behind chronic pain sufferers. There’s substantial science for cannabis’ ability to reduce MS muscle spasms. Meanwhile, others are looking at a potential cannabis-based drug for MS. The cannabis research and development company MMJ International Holdings Corp. hopes to test an experimental medication — a highly purified, liquid plant extract with THC and CBD in a gelatin capsule — for MS in the U.S. soon.   

Cancer pain. Cannabis is highly effective for cancer pain and the side effects of cancer treatment — nausea, vomiting, loss of appetite and weight loss, says Donald Abrams, an oncologist and professor of medicine at the University of California San Francisco and a longtime advocate of medical marijuana. “There’s no question in my mind, it works,” Abrams says. “I was on the NASEM committee that reviewed the evidence.”

The uses with the strongest evidence in the medical literature were for nausea and vomiting caused by chemotherapy and cancer pain. “I work with patients undergoing cancer therapy,” Abrams says. “I tell them, ‘Go to the dispensary, tell them what you’re trying to treat, and ask what works best.’ ” 

But cannabis should never be used to treat cancer, Abrams says. “The saddest and most frustrating thing for me is to meet patients who’ve delayed coming in for six months because they heard marijuana treats cancer and they wanted to try it first. For some, it’s too late for proven treatments like surgery, chemotherapy and radiation that extend and save lives.” Don’t fall for hints online that it does work, he notes — they’re based on sketchy anecdotes and questionable research, like one tiny human study that dripped cannabis into the brains of people with brain cancer.

Other conditions. Older adults are using medical marijuana for dozens of other health concerns, including migraines, fibromyalgia, symptoms of Alzheimer’s disease and dementia, Parkinson’s disease, Crohn’s disease and glaucoma. Some show promise. Medical marijuana reduced the frequency and intensity of migraines in one study. A study of 2,700 older patients in Israel gave cannabis high marks for reducing pain and improving quality of life for those with Alzheimer’s, Parkinson’s, Crohn’s and ulcerative colitis. Meanwhile, experts say that when it comes to glaucoma, do not rely on marijuana. It’s important to stick with proven treatments like eye drops. Far more research and anecdotal weight is needed before there are definitive answers on these uses.

Source: https://tntribune.com/lifestyle/health-wellness/what-studies-say-about-cannabis-effect-on-various-health-conditions/

The post What Studies Say About Cannabis’ Effect on Various Health Conditions – tntribune.com appeared first on CBD Oil Depot.

]]>
Bill would give FDA 120 days to issue policy on CBD – Capital Press https://cbdoildepo.com/bill-would-give-fda-120-days-to-issue-policy-on-cbd-capital-press/ Fri, 20 Sep 2019 07:29:14 +0000 http://CBMilwFodHRwczovL3d3dy5jYXBpdGFscHJlc3MuY29tL25hdGlvbl93b3JsZC9hZ3JpY3VsdHVyZS9iaWxsLXdvdWxkLWdpdmUtZmRhLWRheXMtdG8taXNzdWUtcG9saWN5LW9uLWNiZC9hcnRpY2xlXzU0ZjBlYzc0LWRhZjctMTFlOS05NWI1LTM3YmY1ZTNjMmMzZS5odG1s0gEA One year after Congress legalized industrial hemp in the 2018 Farm Bill, lawmakers are pushing the Food and Drug Administration to finalize rules for classifying and regulating products containing hemp-derived cannabidiol, or CBD. Senate Majority Leader Mitch McConnell — a major backer of industrial hemp in his home state of […]

The post Bill would give FDA 120 days to issue policy on CBD – Capital Press appeared first on CBD Oil Depot.

]]>

One year after Congress legalized industrial hemp in the 2018 Farm Bill, lawmakers are pushing the Food and Drug Administration to finalize rules for classifying and regulating products containing hemp-derived cannabidiol, or CBD.

Senate Majority Leader Mitch McConnell — a major backer of industrial hemp in his home state of Kentucky — wants the FDA to back off enforcement against CBD companies until the agency finishes outlining regulations for products infused with the compound.

McConnell introduced language in the latest Senate Agriculture Appropriations bill that would require the FDA to temporarily adopt an “enforcement discretion” policy for CBD — meaning it would not take enforcement action against companies that put CBD in food or sell it as a dietary supplement.

The FDA would, however, continue to take enforcement action against companies that make specific health claims about CBD products.

The Senate Appropriations Committee approved the $23.1 billion agriculture spending bill on Sept. 19. It now heads to the Senate floor for debate.

If approved, the FDA would have 120 days to adopt an enforcement discretion policy. The agency would also have to provide Congress with an update of its progress after 90 days.

Proponents claim CBD from hemp has numerous health and nutritional benefits, including treatment for anxiety, depression and pain relief. The FDA is responsible for regulating the sale of CBD products, determining if they will be treated as medicine or a dietary supplement.

Hemp itself is a cannabis plant, similar to marijuana except it contains just 0.3% of tetrahydrocannabinol, or THC, the psychoactive component that gets users high.

Sen. Ron Wyden, D-Ore., has said the FDA is dragging its feet on setting up regulations. The bill will help Oregon’s hemp industry continue to create jobs, he said, and put an end to regulatory uncertainty.

“Once passed, this language will again show that congress is serious about the FDA doing its job,” Wyden said.

Oregon Sen. Jeff Merkley, the top Democrat serving on the Senate Agriculture Appropriations Subcommittee, said he secured $2 million in the spending bill for research and market analysis to “appropriately regulate” CBD.

CBD is projected to be a billion-dollar industry for Oregon in 2019, Merkley said during a conference call with reporters. The Nielsen market research firm predicts sales of CBD across the U.S. could reach $6 billion by 2025.

“That would be an extraordinary flow of additional revenue into our agricultural communities,” Merkley said.

The agriculture appropriations bill includes another $2.5 million for hemp innovation research. Oregon State University established the Global Hemp Innovation Center in June, combining more than 40 faculty across 19 academic disciplines researching all aspects of hemp — from cultivation to food and product testing.

More from this section

While CBD currently dominates the hemp market, it can also be used to make products like rope, clothing and “hempcrete,” a type of construction material combining hemp and lime.

Other provisions in the appropriations bill include:

• $5 million for OSU and other West Coast universities to study the effects of wildfire smoke on crops, specifically winegrapes. A California winery rejected 2,000 tons of grapes from Southern Oregon growers just before harvest in 2018 due to concerns about smoke taint, worth an estimated $4 million.

• $120 million funding increase for the USDA Agricultural Research Service.

• $17.5 million for a Value-Added Producer Grant Program, emphasizing the organic hazelnut industry.

• $3.5 million for the USDA Advanced Wood Products Program, which focuses on mass timber products.

Merkley said he is optimistic the bipartisan agriculture appropriations bill will be taken up on the Senate floor “very soon.”

“I made sure this bill makes Oregon’s priorities our national priorities,” Merkley said. “These investments will help Oregonians in every part of the state sell more, reduce costs, develop new products and strengthen our communities.”

Source: https://www.capitalpress.com/nation_world/agriculture/bill-would-give-fda-days-to-issue-policy-on-cbd/article_54f0ec74-daf7-11e9-95b5-37bf5e3c2c3e.html

The post Bill would give FDA 120 days to issue policy on CBD – Capital Press appeared first on CBD Oil Depot.

]]>
Investigation Reveals Hazardous Chemicals in Many CBD Products – Leafly https://cbdoildepo.com/investigation-reveals-hazardous-chemicals-in-many-cbd-products-leafly/ Fri, 20 Sep 2019 06:49:25 +0000 http://52780385006300 Jay Jenkins says he hesitated when a buddy suggested they vape CBD. “It’ll relax you,” the friend assured. The vapor that Jenkins inhaled didn’t relax him. After two puffs, he ended up in a coma. That’s because what he was vaping didn’t have any CBD, the suddenly popular compound extracted […]

The post Investigation Reveals Hazardous Chemicals in Many CBD Products – Leafly appeared first on CBD Oil Depot.

]]>

Jay Jenkins says he hesitated when a buddy suggested they vape CBD.

“It’ll relax you,” the friend assured.

The vapor that Jenkins inhaled didn’t relax him. After two puffs, he ended up in a coma.

That’s because what he was vaping didn’t have any CBD, the suddenly popular compound extracted from the cannabis plant that marketers say can treat a range of ailments without getting users high. Instead, the oil was spiked with a powerful street drug.

Some operators are cashing in on the CBD craze by substituting cheap and illegal synthetic marijuana for natural CBD in vapes and edibles such as gummy bears, an Associated Press investigation has found.

At least 128 samples out of more than 350 tested by government labs in nine states, nearly all in the South, had synthetic marijuana in products marketed as CBD.

The practice has sent dozens of people like Jenkins to emergency rooms over the last two years. Yet people behind spiked products have operated with impunity, in part because the business has boomed so fast that regulators haven’t caught up while drug enforcement agents have higher priorities.

AP commissioned laboratory testing of the vape oil Jenkins used plus 29 other vape products sold as CBD around the country, with a focus on brands that authorities or users flagged as suspect. Ten of the 30 contained types of synthetic marijuana — drugs commonly known as K2 or spice that have no known medical benefits — while others had no CBD at all.

Among them was Green Machine, a pod compatible with Juul electronic cigarettes that reporters bought in California, Florida and Maryland. Four of those seven pods contained illegal synthetic marijuana, but which chemical varied by flavor and even location of purchase.

“It’s Russian roulette,” said James Neal-Kababick, director of Flora Research Laboratories, which tested the products.

Vaping in general has come under increased scrutiny in recent weeks because hundreds of users have developed mysterious lung illnesses, and several have died. The AP’s investigation focused on yet another set of cases, in which psychoactive chemicals are added to products presented as CBD.

The results of AP’s lab testing echo what authorities have found, according to a survey of law enforcement agencies in all 50 states. At least 128 samples out of more than 350 tested by government labs in nine states, nearly all in the South, had synthetic marijuana in products marketed as CBD. Gummy bears and other edibles accounted for 36 of the hits, while nearly all others were vape products. Mississippi authorities also found fentanyl, the powerful opioid involved in about 30,000 overdose deaths last year.

Reporters then bought brands that law enforcement testing or online discussions identified as spiked. Because testing by both authorities and AP focused on suspect products, the results are not representative of the overall market, which includes hundreds of products.

“People have started to see the market grow and there are some fly-by-night companies trying to make a quick buck,” said Marielle Weintraub, president of the U.S. Hemp Authority, an industry group that certifies CBD cosmetics and dietary supplements.

Synthetic marijuana is a concern, according to Weintraub, but she said the industry has many reputable companies. When products turn up spiked, the people or companies behind them often blame counterfeiting or contamination in the supply and distribution chain.

CBD, short for cannabidiol, is one of many chemicals found in cannabis, a plant known more commonly as marijuana. Most CBD available today is made from hemp, a cannabis variety cultivated for fiber or other uses. Unlike its more famous cousin THC, cannabidiol doesn’t get users high. Sales of CBD have been driven in part by unproven claims that it can reduce pain, calm anxiety, increase focus and even prevent disease.

The U.S. Food and Drug Administration has approved one CBD-based medicine for treating seizures associated with two rare and severe forms of epilepsy, but says it cannot be added to food, drinks or dietary supplements. The agency is now clarifying its regulations, but aside from warning manufacturers against making unproven health claims, it has done little to stop the sale of spiked products. That’s the job of the U.S. Drug Enforcement Administration, but its agents are focused on opioids and other narcotics.

Now there are CBD candies and beverages, lotions and creams, and even treats for pets. Suburban yoga studios, big-name pharmacies and Neiman Marcus department stores carry beauty products. Kim Kardashian West had a CBD-themed baby shower.

But it’s hard for consumers to know how much CBD they are really getting, if any at all. As with many products, federal and state regulators rarely test what’s inside — for the most part, quality control is left to manufacturers.

And there’s a financial incentive to cut corners. One website advertises synthetic marijuana for as little as $25 per pound — the same amount of natural CBD costs hundreds or even thousands of dollars.

‘You Only Live Once’

Jay Jenkins had just wrapped up his freshman year at The Citadel, a South Carolina military college, when boredom led him to try what he thought was CBD.

It was May 2018 and he said his friend bought a cartridge of blueberry flavored CBD vape oil called Yolo! — the acronym for “you only live once” — from the 7 to 11 Market, an austere, white board-and-batten building in Lexington, South Carolina.

Back in the car, Jenkins tried it first. Things “got hazy,” then terrifying.

Jenkins said the nerves in his mouth felt like they were “multiplied by 10.” Vivid images including a circle engulfed by darkness and filled with colorful triangles filled his mind. Before he drifted out of consciousness, he realized he couldn’t move.

“I thought that I actually was already dead,” Jenkins said.

Lab testing AP commissioned this summer found a type of synthetic marijuana that has been blamed for at least 11 deaths in Europe.

His friend raced to the hospital where Jenkins suffered acute respiratory failure and drifted into a coma, his medical records show.

Jenkins came out of the coma and was released the next day. Hospital staff sealed the Yolo cartridge in a biohazard bag and handed it back.

Lab testing AP commissioned this summer found a type of synthetic marijuana that has been blamed for at least 11 deaths in Europe.

State and federal authorities never identified who made Yolo, which sickened not just Jenkins but also at least 33 people in Utah.

According to documents filed in a California court by a former company bookkeeper, a business called Mathco Health Corporation sold Yolo products to a distributor with the same address as the 7 to 11 Market where Jenkins stopped. Two other former employees told AP that Yolo was a Mathco product.

“As long as it remains unregulated like it currently is you just give a really wide space for nefarious activity to continue.”

Michelle Peace, Virginia Commonwealth University forensic scientist

Mathco CEO Katarina Maloney said in an interview at company headquarters in Carlsbad, California, that Yolo was handled by her former business partner and she did not want to discuss it.

Maloney also said Mathco does not “engage in the manufacture, distribution or sale of any illegal products.” She said the Yolo products in Utah “were not purchased from us” and the company can’t control what happens to products once they are shipped. AP-commissioned testing of two CBD vape cartridges marketed under Maloney’s Hemp Hookahzz brand found no synthetic marijuana.

As part of an employment complaint filed in court records, the former bookkeeper said Maloney’s former business partner, Janell Thompson, was the “exclusive salesperson” of Yolo. Reached by phone and asked about Yolo, Thompson hung up.

“If you want to speak with somebody you can talk to my attorney,” Thompson later texted without providing a name or contact information.

When a reporter visited the 7 to 11 Market in May, Yolo was no longer for sale. Asked for something similar, the clerk suggested a cartridge labeled Funky Monkey and then turned to a cabinet behind the counter and offered two unlabeled vials

“These are better. These are the owner’s. This is our top seller,” she said, referring to them as 7 to 11 CBD. “These here, you can only get here.”

Testing showed that all three contained synthetic marijuana. The store owner did not respond to messages seeking comment.

What’s in ‘Jungle Juice’?

The people behind spiked vapes leave few clues about who makes them or what’s inside.

Packaging doesn’t identify the companies and their brands have little online presence. Newcomers can simply design a label and outsource production to a wholesaler that deals in bulk.

The opaque system of manufacturing and distribution hampers criminal investigations and leaves victims of spiked products with little recourse.

The AP bought and tested Green Machine pods in flavors including mint, mango, blueberry and jungle juice. Four of the seven pods were spiked and only two had CBD higher than a trace level.

Mint and mango pods bought in downtown Los Angeles contained one type of synthetic marijuana. But while mint and mango pods sold by a vape shop in Maryland were not spiked, a “jungle juice” flavored pod was. It had yet a different synthetic marijuana compound — one health authorities blame for poisoning people in the U.S. and New Zealand. A blueberry flavored pod sold in Florida also was spiked.

Green Machine’s packaging says it’s made with industrial hemp, but there’s no information about who is behind it.

When a reporter returned to CBD Supply MD in a Baltimore suburb to discuss testing results, co-owner Keith Manley said he was aware of online chatter that Green Machine might be spiked. He then had an employee pull all remaining Green Machine pods from store shelves.

Through interviews and documents, AP tracked Green Machine pods that reporters bought to a warehouse in Philadelphia and then a Manhattan smoke shop and the entrepreneur behind the counter, Rajinder Singh, who said he is Green Machine’s first distributor.

Singh, who is currently on probation for a federal synthetic marijuana conviction, said he purchased Green Machine pods with cash or in exchange for merchandise such as hookah pipes from a man he knew as “Bob” who drove a van down from Massachusetts. To substantiate his account, he provided a phone number associated with a man who died in July.

Singh pleaded guilty in 2017 to federal charges he sold a smokable “potpourri” that he knew contained synthetic marijuana. He said that experience taught him a lesson and blamed counterfeit products for the synthetic marijuana detected in Green Machine.

“100 percent, what you tested is a duplicated product,” he said.

‘Emerging Hazard’

The American Association of Poison Control Centers considers CBD an “emerging hazard” due to the potential for mislabeling and contamination.

One case last year involved an 8-year-old boy from Washington who was hospitalized after taking CBD oil his parents ordered online in hopes it would help his seizures, according to a case study in the journal Clinical Toxicology published in May. Instead, synthetic marijuana sent him to the hospital with symptoms including delirium and a rapid heart rate.

Other clusters of illnesses happened in Mississippi and around military bases in North Carolina.

Labeling of many CBD products has been documented as inaccurate. A 2017 study in the Journal of the American Medical Association found 70% of CBD products were mislabeled. Researchers used an independent lab to test 84 products from 31 companies.

Fake or spiked CBD is enough of a concern that leaders of the U.S. Hemp Authority industry group developed a certification program for CBD skin and health products. Vapes are not covered.

But local and state authorities have limited ability to pursue problem products to their roots.

After several Georgia high school students passed out from vaping last year, authorities began scrutinizing local tobacco shops. One of the CBD vape brands they targeted was called Magic Puff.

The drug enforcement team in Savannah and surrounding Chatham County arrested a shop owner and two employees. But they couldn’t follow the investigation further because it appeared the products were being manufactured elsewhere, possibly overseas. The team’s assistant deputy director, Gene Harley, said they provided a report to federal drug agents who handle such cases.

Magic Puff was still on shelves at a Florida store this summer, and AP testing showed blueberry and strawberry cartridges contained synthetic marijuana. Preliminary results also suggested the presence of a toxin produced by a fungus.

Because CBD is the active ingredient in an FDA-approved drug, the FDA is responsible for regulating its sale in the U.S. But if CBD products are found to contain narcotics, the agency considers the investigation a job for the DEA, an FDA spokesman said.

The DEA says it is focused on drugs responsible for killing thousands of Americans like fentanyl and methamphetamines.

“These are going to be bigger priorities on enforcement,” DEA spokeswoman Mary Brandenberger said.

Experts such as Michelle Peace, a forensic scientist at Virginia Commonwealth University who has found synthetic marijuana in her own testing of CBD vapes, said the federal government should act quickly to protect the public.

“As long as it remains unregulated like it currently is,” Peace said, “you just give a really wide space for nefarious activity to continue.”

Source: https://www.leafly.com/news/health/cbd-vapes-synthetic-cannabinoids

The post Investigation Reveals Hazardous Chemicals in Many CBD Products – Leafly appeared first on CBD Oil Depot.

]]>
Unwind naturally with CBD | – Left Hand Valley Courier https://cbdoildepo.com/unwind-naturally-with-cbd-left-hand-valley-courier/ Fri, 20 Sep 2019 06:49:23 +0000 http://CBMiX2h0dHA6Ly93d3cubGh2Yy5jb20vdW53aW5kLW5hdHVyYWxseS13aXRoLWNiZC9hcnRpY2xlXzFkMWUyMDIwLWRhN2QtMTFlOS04YmRlLTJmYTFlN2IzY2Q2OS5odG1s0gEA Three letters you’re likely seeing everywhere these days – CBD. You can’t miss CBD in healthcare offices, coffee shops, pharmacies, marijuana dispensaries, and there it is again on the shelves at your favorite food store. Your pet can get its own version of CBD in drops and treats. Why all […]

The post Unwind naturally with CBD | – Left Hand Valley Courier appeared first on CBD Oil Depot.

]]>

Three letters you’re likely seeing everywhere these days – CBD. You can’t miss CBD in healthcare offices, coffee shops, pharmacies, marijuana dispensaries, and there it is again on the shelves at your favorite food store. Your pet can get its own version of CBD in drops and treats.

Why all the buzz about CBD? It’s because the natural substance Cannabidiol (CBD’s proper name) is making life a whole lot more pleasant for many people. Most evidence thus far is anecdotal, with testing lagging behind but it’s believed that CBD eases mental health issues such as anxiety and post-traumatic stress disorder, improves moods, and offers pain relief for migraines and arthritis. Other positive effects include calming skin afflictions, relief from opioid addiction, reducing Multiple Sclerosis symptoms, and alleviating insomnia.

The most solid testing has been done in the field of epilepsy and results have been excellent when it comes to reducing and even eliminating certain types of seizures in young children.

How does CBD work?

It’s a complicated explanation revolving around the body’s endocannabinoid system (ECS), which is responsible for maintaining balance in the presence of stressors. Basically our bodies already work with cannabinoids and introducing them externally through CBD products can help to maintain vital immune and central nervous systems functions.

Is CBD weed?

Nope, it’s a derivative of hemp, which is in the same genus of plants as marijuana – the cannabis family. Marijuana contains CBD, but CBD has no psychoactive effects and should not be confused with THC (Tetrahydrocannabinol), the active ingredient in marijuana which gives users a high.

Hemp-derived CBD contains less than .3% THC (as opposed to marijuana which contains 5% or more) making it so miniscule that there’s no altering effect.

Laws controlling CBD still make up a tangled web at the federal level, but Colorado statutes allow the sale of CBD products over the counter.

A report put out by the Food and Drug Administration in July stated, “The FDA is working to learn more about the safety of CBD and CBD products.” Because, aside from epilepsy medication, cannabinoid products don’t go through FDA approval, the agency also warns that assertions made about each product’s level of CBD and effectiveness may fall short of the manufacturers’ claims.

Will it work?

How each person metabolizes CBD makes outcomes something of a wildcard. Some brains are more receptive to the chemical; others feel little or no difference. If you haven’t felt anything after using CBD, there are a few things that may be playing into it: it’s possible you’re using an inferior product, you may need to switch to a different type of product (like from a cream to an edible) or you may need to give it time to build up in your system.

Want to give it a try?

  • Do some research before purchasing a product, especially to be sure it has been lab tested by a third party. It should state that on the product label or on the website.
  • Be aware that if your employer requires drug testing, consumption of higher doses of CBD can lead to a test failure.
  • Vaping CBD puts it directly into your lungs and can be the quickest method. However, current warnings surrounding the safety of vaping should be heeded.

CBD in the hood

Niwot Natural Medicine – Dr. Janine Malcolm, ND said, “I love CBD oil, it can be very beneficial for certain people. The issue is the quality. A lot of the products on the market are not clean or they’re toxic.” Malcolm’s practice carries two lines of products in its apothecary (bath salts, oils/creams, and tinctures) which meet her standards: Moon Mother Hemp Company and Quick Silver Scientific.

Niwot Market – In the cooler section and on shelves near checkout stands you’ll find Sparkling Beverages CBD infused drinks, One Love Teas, and snacks including Moksha Chocolates, Numb Nuts, and a variety of lotions and body care.

Starbuds Niwot Dispensary – Dispensaries sell products with the blend of CBD and THC. That combo is touted as being the best for pain relief, both inflammatory and neuropathic, and best for cancer patients. An advantage to buying from a dispensary is that the products are all tested by a regulatory agency. Starbuds’ staff is knowledgeable about their patches, bath bombs, creams, and tinctures. Owner Ernie Craumer said, “Our store in Niwot sells a lot of CBD products primarily due to the age breakdown – a higher age group. Sleep ailments and pain management are the two major reasons our customers buy it.”

Gunbarrel Liquor Store – Owner Lauren Touch said they’ve just started to carry CBD beverages and they’re all delicious. Otto’s non-alcoholic CBD infused ciders and a variety of CBD gummies are now on the shelves. Touch also mentioned that “the most amazing sodas ever” will soon be in the store – Backyard Soda Company with full spectrum CBD hemp extract.

Flatirons Family Pharmacy in Longmont – The pharmacy has a large CBD section which includes products by Restorative Botanicals, That’s Natural!, Moon Mother Hemp, Exult, and Suzie’s CBD Treats for pets

Source: http://www.lhvc.com/unwind-naturally-with-cbd/article_1d1e2020-da7d-11e9-8bde-2fa1e7b3cd69.html

The post Unwind naturally with CBD | – Left Hand Valley Courier appeared first on CBD Oil Depot.

]]>
Illinois officials claim possible first death from vaping-related illness; investigation ongoing – USA TODAY https://cbdoildepo.com/illinois-officials-claim-possible-first-death-from-vaping-related-illness-investigation-ongoing-usa-today/ Fri, 20 Sep 2019 06:49:16 +0000 http://CAIiEPYoC-ZZ6ojFuvMlZpGUSQ0qGQgEKhAIACoHCAowjsP7CjCSpPQCMM_b5QU CLOSE Juul dominated the e-cigarette industry, prompting the FDA to call teen vaping an “epidemic.” What does vaping do to your body? We explain. Just the FAQs, USA TODAY An Illinois resident who had recently vaped and was hospitalized with severe respiratory illness has died, the Illinois Department of Public Health said […]

The post Illinois officials claim possible first death from vaping-related illness; investigation ongoing – USA TODAY appeared first on CBD Oil Depot.

]]>
CLOSE

Juul dominated the e-cigarette industry, prompting the FDA to call teen vaping an “epidemic.” What does vaping do to your body? We explain. Just the FAQs, USA TODAY

An Illinois resident who had recently vaped and was hospitalized with severe respiratory illness has died, the Illinois Department of Public Health said in a statement Friday.

As of Thursday, the CDC had not reported any deaths from vaping-related illnesses, making the Illinois case a possible first in the nation.

“This is the first death of an individual in Illinois who has been hospitalized for severe respiratory illness with reported vaping-e-cigarette use,” said Melaney Arnold, the department’s health information officer.

Illinois health officials did not say whether an autopsy was completed to determine the cause and manner of the person’s death. It is unclear if the individual had any pre-existing conditions.

CDC: 153 possible cases of vaping-related illnesses, many involving THC

Life-threatening breathing illnesses: Vaping could be cause, doctor says

In order to protect the identity of the affected individual, additional information is not being provided at this time, Arnold said. The investigation is ongoing and more information will be shared as it is available.

The number of cases reported to the Illinois Department of Public Health of people who have used e-cigarettes or vaped and have been hospitalized with respiratory symptoms has doubled in the past week, the state department said.

“The severity of illness people are experiencing is alarming and we must get the word out that using e-cigarettes and vaping can be dangerous,” said Dr. Ngozi Ezike, director of the Illinois Department of Public Health. “We requested a team from the Centers for Disease Control and Prevention (CDC) to help us investigate these cases and they arrived in Illinois on Tuesday.”

A total of 22 people in Illinois, ranging in age from 17-38 years, have experienced respiratory illness after using e-cigarettes or vaping, the department said. The department is working with local health departments to investigate another 12 individuals.

Affected individuals have experienced respiratory symptoms including cough, shortness of breath, and fatigue, the statement said. Some also experienced vomiting and diarrhea.

“This tragic death in Illinois reinforces the serious risks associated with e-cigarette products. Vaping exposes users to many different substances for which we have little information about related harms – including flavorings, nicotine, cannabinoids, and solvents,” Dr. Robert R. Redfield, Director of the Centers for Disease Control and Prevention, said in a statement Friday.

Reports of vaping-related illnesses on the rise

Concerns about vaping-related illnesses have spiked in recent months. The Centers for Disease Control and Prevention initially announced Wednesday that 153 possible cases of severe lung illness linked to vaping were reported across 16 states in just the past two months. By Thursday, that number had jumped to 193 potential cases across 22 states. Many cases involved the use of products containing tetrahydrocannabinol (THC), the psychoactive chemical found in cannabis.

The Illinois statement did not say whether the man had been vaping THC.

Possible cases were reported in: California, Connecticut, Florida, Illinois, Indiana, Iowa, Minnesota, Michigan, North Carolina, New Jersey, New Mexico, New York, Pennsylvania, Texas, Utah and Wisconsin, with additional states pending verification. Similar cases have also been reported in three additional states – Ohio, Virginia and Tennessee, according to NBC News. Wisconsin has seen at least 15 cases, including vaping-related lung illnesses among older people.

Dr. Ngozi Ezike told CNN earlier this month that a number of vaping-related lung illnesses occurred among people with “no known lung problems or previously diagnosed pulmonary issues.”

Dr. Melodi Pirzada, chief of pediatric pulmonology at NYU Winthrop Hospital, told USA TODAY that it is possible a patient with no previous health conditions could die from a vaping-related illness. “Yes, you can die from vaping. I had a patient who almost died,” Pirzada said Friday.

Just last month, Pirzada was able to save an 18-year-old man who was put in a medically induced coma after vaping cannabis oil.

Similarly, Texas teen Tryston Zohfeld narrowly escaped death this month when his lungs inflamed and became blocked. Much like the case at NYU, doctors initially thought Zohfeld had pneumonia until a friend revealed that Zohfeld had a vaping habit, according to WFAA-TV.

Dr. Karen Schultz, a specialist in pediatrics and pulmonology in Fort Worth, told WFAA-TV she believes vaping caused Zohfeld’s lungs to fail. Zohfeld was released from the hospital after 18 days.

In Salt Lake City, Intermountain Healthcare Pulmonologist Dr. Dixie Harris has been involved with four cases of vaping-related illnesses. Two of her patients almost died.

“From the cases that I’ve been involved with here at our facilities, we’ve had at least two on ventilators. And at that point, there’s always a risk of passing away,” Harris said.

Harris and her team have been working on a definition to describe these illnesses. “They come into the hospital. They have chest x-rays that look like pneumonia, but they don’t have an infection. And they’re vaping—with nicotine, marijuana or both. That’s how we’re defining our cases,” Harris said.

Parents beware: Here are 5 types of e-cigarettes your teen might be hiding

Warning: Vaping teens becoming a new generation of nicotine addicts

The Food and Drug Administration has joined the CDC investigation and is providing technical and laboratory assistance to help identify any products or substances used.

“We continue to call on the CDC and FDA to not only promptly investigate these incidents, but also act to ensure that adult smokers know that nicotine vaping products remain a far safer alternative to smoking,” said American Vaping Association President Gregory Conley.

Vaping-related illnesses aren’t the only dangers e-cigarettes pose. At least two Americans have died after their e-cigarettes exploded. In 2019, a 24-year-old Texas man died after an exploding e-cigarette cut an artery in his neck and triggered a stroke. In 2018, a 38-year-old Florida man died after his e-cigarette exploded and burned 80% of his body.

Follow Grace Hauck on Twitter @grace_hauck.

Autoplay

Show Thumbnails

Show Captions

Read or Share this story: https://www.usatoday.com/story/news/nation/2019/08/23/vaping-death-illinois-man-who-recently-used-e-cigarette-dies/2096212001/

Source: https://www.usatoday.com/story/news/nation/2019/08/23/vaping-death-illinois-man-who-recently-used-e-cigarette-dies/2096212001/

The post Illinois officials claim possible first death from vaping-related illness; investigation ongoing – USA TODAY appeared first on CBD Oil Depot.

]]>
Nabis Holdings Launches BIS, A New CBD Exclusive Brand – Yahoo Finance https://cbdoildepo.com/nabis-holdings-launches-bis-a-new-cbd-exclusive-brand-yahoo-finance/ Fri, 20 Sep 2019 06:29:58 +0000 http://CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9uYWJpcy1ob2xkaW5ncy1sYXVuY2hlcy1iaXMtY2JkLTA0MDAwMDA3My5odG1s0gFVaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvbmFiaXMtaG9sZGluZ3MtbGF1bmNoZXMtYmlzLWNiZC0wNDAwMDAwNzMuaHRtbA VANCOUVER, British Columbia, Sept. 12, 2019 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (NAB.CN) (OTC:NABIF) (FRA:A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the launch of BIS (Be In Synergy), its new exclusive brand of […]

The post Nabis Holdings Launches BIS, A New CBD Exclusive Brand – Yahoo Finance appeared first on CBD Oil Depot.

]]>
VANCOUVER, British Columbia, Sept. 12, 2019 (GLOBE NEWSWIRE) — Nabis Holdings Inc. (NAB.CN) (OTC:NABIF) (FRA:A2PL) (“Nabis™” or the “Company”), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the launch of BIS (Be In Synergy), its new exclusive brand of cannabidiol (“CBD”) product lines. BIS was created with the mission to develop innovative, high quality, efficient and safe consumer products through unique formulations and technologies that optimize the use and effects of cannabis. The BIS inaugural line of products is anticipated to be available for sale in late 2019.

The BIS brand includes a variety of exciting product lines to meet consumers’ medical, lifestyle and wellness needs. The BIS launch will include SKUs for edibles, vapes, patches, cosmetics, skincare and hair products. In addition, BIS has exclusive rights in the U.S. for a state-of-the-art spray oral delivery system for various cannabis-based products such as oils and liquids. This unique delivery system has an air and watertight design that will prolong shelf-life and enhance product quality.

Of note, the BIS brand will launch the BIS sublingual films developed with Cannova, a provider of innovative solutions for cannabis consumption that are designed to mask the taste of cannabinoids and increase solubility. Sublingual strips, which are consumed by under-the-tongue placement, allow for rapid absorption in which cannabinoids bypass the liver metabolism.

“Nabis has always been dedicated to the development and distribution of only the highest quality products,” said Shay Shnet, CEO & Director of Nabis. “Our creation of the BIS brand of CBD products reflect our commitment to excellence and consumer satisfaction. As we continue to expand the BIS brand, we are excited to present an elegant product line that we believe will fill a demand that has remained unmet in the cannabis and CBD industry until now.”

BIS products will be available for purchase in the U.S. in-store at Nabis dispensary locations and online at the BIS ecommerce site www.beinsynergy.com anticipated to launch late 2019.

Nabis announces that further to its press release dated January 29, 2019, its intention to acquire 100% of the membership units of Organica Patient Group Inc. (“OPG”), and RDF Management Group (“RDF”), and its press release dated January 28, 2019 to invest in a 70% interest of Hivemind Refinery (“HIVEMIND”), has been terminated. Nabis intends to pursue other opportunities and is no longer proceeding with the transactions.

About Nabis Holdings Inc.
Nabis Holdings is a Canadian investment issuer that invests in high quality cash flowing assets across multiple industries, including real property, securities, cryptocurrency, and all aspects of the U.S. and international cannabis sector. Led by two of the co-founders of MPX Bioceutical, one of the largest takeovers in the U.S. Cannabis space to date, the company has a proven track record in emerging markets to create significant shareholder value. The Company is focused on investing across the entire vertically integrated aspects of the space with a focus on revenue generation, EBITDA and growth.

For more information, please visit https://www.nabisholdings.com/.

Forward-Looking Statements
All statements, other than statements of historical fact, included herein are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The risks are without limitations: that the acquisitions will be completed by the Company or completed upon the terms disclosed; the price for cannabis and related products will remain consistent and the consumer demand remains strong; availability of financing to the Company to develop the retail locations; retention of key employees and management; changes in State and/or municipal regulations of retail operations and changes in government regulations generally. Important factors that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time with the Canadian Securities Exchange, the British Columbia Securities Commission, the Ontario Securities Commission and the Alberta Securities Commission.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

For inquiries, please contact:

Investor Contact:
Allison Soss
KCSA Strategic Communications
PH: 212-896-1267
Nabis@kcsa.com

Company Contact:
Shay Shnet, CEO and Director
PH: 905-581-5521 x107
info@nabisholdings.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/07074110-769d-46bb-ace2-6a02f681dc70

Source: https://finance.yahoo.com/news/nabis-holdings-launches-bis-cbd-040000073.html

The post Nabis Holdings Launches BIS, A New CBD Exclusive Brand – Yahoo Finance appeared first on CBD Oil Depot.

]]>
A Hempire State of Mind at Hudson Valley Farms – SUNY The New Paltz Oracle https://cbdoildepo.com/a-hempire-state-of-mind-at-hudson-valley-farms-suny-the-new-paltz-oracle/ Fri, 20 Sep 2019 06:19:04 +0000 http://CBMiS2h0dHBzOi8vb3JhY2xlLm5ld3BhbHR6LmVkdS9hLWhlbXBpcmUtc3RhdGUtb2YtbWluZC1hdC1odWRzb24tdmFsbGV5LWZhcm1zL9IBAA The people’s plant is back. It’s not going away, and the Hudson Valley farmers are certainly not going to be excluded from this. Gail Hepworth and her sister, Amy, own and operate Hepworth Farms in Milton, a 550-acre, seventh-generation family farm. As well as cultivating more than 300 varieties of […]

The post A Hempire State of Mind at Hudson Valley Farms – SUNY The New Paltz Oracle appeared first on CBD Oil Depot.

]]>

The people’s plant is back. It’s not going away, and the Hudson Valley farmers are certainly not going to be excluded from this.

Gail Hepworth and her sister, Amy, own and operate Hepworth Farms in Milton, a 550-acre, seventh-generation family farm. As well as cultivating more than 300 varieties of vegetables, the sisters are now growing hemp. 

“The Hemp Farming Act,” included in the 2018 Farm Bill, removed hemp from the category of a controlled substance and established it as an agricultural commodity. Now that federal prohibition on hemp farming has ceased, the door to new opportunities has opened for Hudson Valley farmers.

“The cannabis plant is an inevitable reality,” Gail said. “It would be remiss of us as professional agricultural people to ignore the potential.”

Earlier this year, the Hepworth sisters co-founded “Hempire State Growers Hudson Valley” in an attempt to safeguard the interests of local farmers growing hemp.

“We’re here to establish the Hudson Valley as a CBD growing region for farmers, for food production and for the agricultural landscape that already exists,” Gail claimed. 

Because hemp plants contain cannabidiol, otherwise known as CBD, the resin from the hemp plants’ stalks can be extracted and combined with coconut or olive oil to create a natural form of pain relief. Without THC—the substance in marijuana plants that gets a person high—CBD is both non-addictive and non-psychoactive, and has the ability to foster good health and wellness without altering a person’s perceptions. 

Scientific studies reveal that CBD oil is helpful in reducing the symptoms of a wide variety of conditions, including anxiety, sleep paralysis, high blood pressure and even side-effects associated with cancer treatments. 

Amy seized the opportunity to capitalize on the economic trajectory of this plant and support local farmers through this market. Currently there are more than 30 local farmers involved in Hempire State Growers, and additional farmers are expected to join by next year.

“There aren’t that many regions that are futuristically viable as the Hudson Valley,” Gail said. “We might be one of the last regions standing, so we have to do all that we can to preserve agriculture here in the Hudson Valley. We would be remiss if we didn’t take this new crop, which is actually an old crop, and integrate it into our farm.” 

In the 1930s, hemp was on its way to become a billion-dollar industry, with Henry Ford being one of its most notable advocates. However, when the Marijuana Tax Act was passed in 1937, it levied a high tax on anyone involved in commercial cannabis, nearly destroying the American hemp industry. It is believed that notable businessmen like Andrew Mellon, Randolph Hearst and the DuPont family lobbied against hemp to protect and further their own economic interests in the timber, paper and synthetic fiber industries.

One of Hempire State Growers’ biggest concerns is that the capitalistic mindset of corporations could undermine local farmers’ interests and well-being. 

“The challenge is that this could be business as usual. Big businesses are taking over farm land because they see the potential, and it has nothing to do with farming, it has nothing to do with agriculture, it has to do with people making a lot of money,” Gail said. “The farmers who have been struggling will probably pay the ticket and say ‘here you go.’ They will sell out because there is no alternative.”

Over the course of history, limited and inequitable income from vegetable, fruit and field crop farming in New York State has left many farmers vulnerable to low production, insolvency, or even worse, forced into selling their farms.

“Hudson Valley farmers have not traditionally had a profit-sharing mechanism to help them benefit from economies of scale, leverage their efforts against more profitable businesses within the supply chain, and ultimately bolster their competitiveness and economic viability,” according to the Hempire State Growers’ website. “Our bottom-up approach to vertical integration in hemp production and processing, allows for profit-sharing from seed to sale. We see the new hemp industry as an opportunity to ensure the economic viability of the farms in our region.”

Despite the group’s name, growing hemp is not their main prerogative. It’s survival. 

“We’re only growing [hemp] because we want to stay in the business of growing fruits and vegetables and grain crops,” Gail stated. “We are farmers; we’re not trying to be hemp farmers. We’re trying to keep farmers farming.”

A top priority for Hempire State Growers is education, for there is a lack of knowledge surrounding hemp plants.  

“Because people don’t understand what this crop is, we do have a security threat,” Gail testified. “People see this crop and think it’s marijuana. We have security measures in place that we’ve never had to have because it’s not the same thing as tomatoes or apples. We have to educate people because people don’t understand what this crop is.” 

For the 2019 harvest season, Hempire State Growers has over 1,000 acres of hemp planted for field production. To keep this market lucrative for the regional farmers involved, it must be an all hands on deck effort. 

“We actually don’t know where everything is going to land. There are risks involved. Farmers going alone will not be a long-term solution,” Gail said. “We need to work together to create something that is different, different from what we have experienced, different from what is the status quo. We’re looking for this to be a once in a lifetime differentiator and it involves growing a high quality plant.”

Source: https://oracle.newpaltz.edu/a-hempire-state-of-mind-at-hudson-valley-farms/

The post A Hempire State of Mind at Hudson Valley Farms – SUNY The New Paltz Oracle appeared first on CBD Oil Depot.

]]>
CBD for pets: Where’s the scientific evidence? – The GrowthOp https://cbdoildepo.com/cbd-for-pets-wheres-the-scientific-evidence-the-growthop/ Fri, 20 Sep 2019 05:59:05 +0000 http://CBMiV2h0dHBzOi8vd3d3LnRoZWdyb3d0aG9wLmNvbS9jYW5uYWJpcy1oZWFsdGgvY2JkLWZvci1wZXRzLXdoZXJlcy10aGUtc2NpZW50aWZpYy1ldmlkZW5jZdIBW2h0dHBzOi8vd3d3LnRoZWdyb3d0aG9wLmNvbS9jYW5uYWJpcy1oZWFsdGgvY2JkLWZvci1wZXRzLXdoZXJlcy10aGUtc2NpZW50aWZpYy1ldmlkZW5jZS9hbXA Pet parents are increasingly turning to cannabidiol, popularly known as CBD, a cannabis compound, to soothe their four-legged friends’ pain, anxiety, inflammation, and a variety of other ailments. Even though there are hundreds of anecdotal accounts of cannabinoid therapy working as an effective treatment for animals, how does cannabis really […]

The post CBD for pets: Where’s the scientific evidence? – The GrowthOp appeared first on CBD Oil Depot.

]]>

Pet parents are increasingly turning to cannabidiol, popularly known as CBD, a cannabis compound, to soothe their four-legged friends’ pain, anxiety, inflammation, and a variety of other ailments.

Even though there are hundreds of anecdotal accounts of cannabinoid therapy working as an effective treatment for animals, how does cannabis really affect pets and what scientific evidence do we have substantiating those claims?

Virtually none, as it turns out.

There are less than 60 papers and studies listed on the online medical database PubMed regarding cannabis and dogs. Most studies relate to the toxic effects of accidental canine cannabis ingestion, consumption of synthetic cannabinoids, or studies of toxicity via experimental administration. There are a few studies in which CBD seems to have possibly been effective in improving symptoms of pain and reducing epileptic seizures in dogs. But those studies have been small and few.

Dogs possess a larger number of cannabinoid receptors than humans making them potentially more susceptible to the toxic effects of the drug than their human counterparts. In one study from Colorado, two dogs died after consuming edibles containing high-THC cannabis butter — there are no verified reports of cannabis causing an overdose-related death in people.

For now, researchers and veterinarians agree that more research is needed with regards to the administration of cannabis products to pets.

“There are differences in the CB2 receptors and in the metabolism of cannabinoids in dogs compared with humans and veterinary medical researchers should ensure that they become involved in parallel research on the potential value of marijuana for treatment of animal diseases,” writes Ontario Veterinary College professor Carlton Gyles, noting that  “marijuana cookies may well find a place in the veterinarian’s arsenal for treatment of epilepsy and the side-effects of cancer.”

As for other pets such as cats, horses, and rabbits, there is even less information about the effects of therapeutic cannabinoid treatment. Meanwhile, veterinarians in Canada are not legally permitted to prescribe cannabinoids but other countries such as the UK are exploring the possibilities of CBD in veterinary medicine.

While companies such as CannaHorse are working to research safe and effective veterinary applications for CBD, no pet parent should administer cannabis without first consulting a qualified veterinarian.

Want to keep up to date on what’s happening in the world of cannabis?  Subscribe to the Cannabis Post newsletter for weekly insights into the industry, what insiders will be talking about and content from across the Postmedia Network.

Source: https://www.thegrowthop.com/cannabis-health/cbd-for-pets-wheres-the-scientific-evidence

The post CBD for pets: Where’s the scientific evidence? – The GrowthOp appeared first on CBD Oil Depot.

]]>
The Central Park Five: A cautionary tale of injustice https://cbdoildepo.com/the-central-park-five-a-cautionary-tale-of-injustice/ https://cbdoildepo.com/the-central-park-five-a-cautionary-tale-of-injustice/#respond Fri, 20 Sep 2019 02:49:50 +0000 https://cbdoildepo.com/the-central-park-five-a-cautionary-tale-of-injustice/ Wrongly convicted as teenagers for a crime that shocked New York City, the five men who came to be known as the "Central Park Five," who were exonerated by a jailhouse confession and DNA tests, are the subjects of a new Netflix miniseries. Correspondent Maurice DuBois talks with Yusef Salaam, Antron McCray, Raymond Santana, Korey…

The post The Central Park Five: A cautionary tale of injustice appeared first on CBD Oil Depot.

]]>

Wrongly convicted as teenagers for a crime that shocked New York City, the five men who came to be known as the “Central Park Five,” who were exonerated by a jailhouse confession and DNA tests, are the subjects of a new Netflix miniseries. Correspondent Maurice DuBois talks with Yusef Salaam, Antron McCray, Raymond Santana, Korey Wise and Kevin Richardson, and with Ava DuVernay, director of “When They See Us.”

Subscribe to the “CBS Sunday Morning” Channel HERE:
Get more of “CBS Sunday Morning” HERE:
Follow “CBS Sunday Morning” on Instagram HERE:
Like “CBS Sunday Morning” on Facebook HERE:
Follow “CBS Sunday Morning” on Twitter HERE:
Follow “CBS Sunday Morning” on Google+ HERE:

Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE:

Get your news on the go! Download CBS News mobile apps HERE:

Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free!


“CBS Sunday Morning” features stories on the arts, music, nature, entertainment, sports, history, science, Americana and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.

The post The Central Park Five: A cautionary tale of injustice appeared first on CBD Oil Depot.

]]>
https://cbdoildepo.com/the-central-park-five-a-cautionary-tale-of-injustice/feed/ 0